首頁 > 市場調查報告書 > 製藥

生長激素市場:劑型，各用途，各流通管道，各地區-規模，佔有率，展望，機會分析，2023年～2030年

市場調查報告書

商品編碼

1349825

生長激素市場:劑型，各用途，各流通管道，各地區-規模，佔有率，展望，機會分析，2023年～2030年

Somatropin Market, By Dosage Form, By Application, By Distribution Channel, and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)-Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年07月27日 | 出版商:

Coherent Market Insights | 英文 240 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預估 2023 年全球生長激素市場價值 38.5 億美元，預測期內（2023-2030 年）複合年增長率為 7.3%。

報告範圍		報告詳細資料
基準年	2022	2023 年市場規模	美國：38.5億美元
過去的資料	2018年至2021年	預測期間	2023-2030
預測 2023-2030 年複合年增長率：	7.30%	2030年價值預測	63億美元

生長激素注射液用於取代患有生長激素缺乏症的成人和兒童的生長激素（體內產生的天然激素）。生長激素注射液也用於促進患有某些影響正常生長和發育的疾病的兒童的生長。生長激素注射劑以溶液（液體）形式裝在預先裝載的劑量筆或藥筒中，或以粉末形式裝在小瓶或藥筒中，與液體混合並皮下注射（皮下）。當生長激素注射劑用於取代成人生長激素時，通常每天注射一次。生長激素注射液（Serostim）用於增加患有愛滋病毒相關消耗症候群的人類免疫缺陷病毒（HIV）患者的體重和身體耐力。生長激素注射液（Zolbutib）用於治療透過靜脈治療接受額外營養或液體的成人短腸症候群。Somatropin 是一種人類生長激素 (hGH) 類似物。它的作用是取代體內正常產生的生長激素，從而促進生長、體重增加以及改善腸道對營養和水分的吸收。當注射生長激素來取代生長激素或促進兒童生長時，通常每天注射一次，每週注射 3 至 7 天。監管機構增加產品上市和產品批准，提高生長激素治療對生長激素缺乏兒童的長期療效，預計將在預測期內推動全球生長激素市場的成長。

市場動態

監管產品核准的增加以及生長激素缺乏兒童生長激素治療的長期療效預計將在預測期內推動全球生長激素市場的成長。例如，生產藥品的 Ascendis Pharma A/S 公司於 2022 年 1 月被歐盟委員會（EC）診斷為因內源性生長激素分泌不足而促使生長缺陷（又稱生長激素缺乏症，GHD）。該公司宣布，其Lonapegsomatropin Ascendis Pharma（以TransCon hGH 名稱開發）已獲得上市批准，作為每週一次的皮下注射劑，用於治療3 至18 歲的兒童和青少年。TransCon hGH 是一種生長激素前藥，可在體內以治療水平持續釋放未修飾的生長激素 (hGH)。

本調查的主要特徵

本報告提供以2022年為基準年的預測期間（2023-2030 年）之全球生長激素市場的市場規模和復合年增長率（CAGR %）相關的詳區隔析。
並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球生長激素市場的主要參與者之企業簡介。
藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
全球生長激素市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以透過全球生長激素市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

Novo Nordisk A/S
Pfizer, Inc.
Eli Lilly and Company
Changchun GeneScience Pharmaceutical Co., Ltd.
Sandoz International GmbH
Ipsen Pharma
LG Chem
Merck KGaA
Genentech, Inc.
Ferring B.V.
AnkeBio Co., Ltd
Reliance Life Sciences
JCR Pharmaceuticals Co., Ltd
Zhongshan Sinobioway Hygene Biomedicine Co., Ltd
USV Private Limited

第10章章節

調查手法
關於出版社

簡介目錄

Product Code: CMI4062

Global somatropin market is estimated to be valued at US$ 3.85 Billion in 2023 and is expected to exhibit a CAGR of 7.3% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 3.85 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.30%	2030 Value Projection:	US$ 6.30 Bn

Somatropin injections are used to replace growth hormone (a natural hormone produced by the body) in adults and children with growth hormone deficiency. Somatropin injections are also used to increase growth in children with certain conditions that affect normal growth and development. Somatropin injection comes as a solution (liquid) in prefilled dosing pens and cartridges and also as a powder in vials and cartridges to be mixed with liquid to be injected subcutaneously (under the skin). When somatropin injections are given to replace growth hormone in adults, it is usually given once a day. Somatropin injections (Serostim) are used to increase body weight and physical endurance in patients with the human immunodeficiency virus (HIV) who have HIV-associated wasting syndrome. Somatropin injections (Zorbtive) are used to treat short bowel syndrome in adults who are receiving additional nutrition or fluids from intravenous (IV) therapy. Somatropin is a human growth hormone (hGH) analog. It works by replacing growth hormones that are normally produced in the body, which may result in increased growth, body weight, and improved absorption of nutrients and fluids from the intestines. When somatropin injection to replace growth hormone or increase growth in children, it is usually given once daily for 3 to 7 days each week. Increasing product launches or product approvals by the regulatory authorities and an increase in the long term effect of growth hormone therapy on children with growth hormone deficiency are expected to fuel the growth of the global somatropin market over the forecast period.

Market Dynamics

Increasing product approval by regulatory authorities and an increase in the long term effect of growth hormone therapy on children with growth hormone deficiency is expected to fuel growth of the global somatropin market over the forecast period. For instance, in January, 2022, Ascendis Pharma A/S, a company that manufactures pharmaceutical products, announced that the European Commission (EC) granted marketing authorization for Lonapegsomatropin Ascendis Pharma (developed under the name TransCon hGH) as a once-weekly subcutaneous injection for the treatment of children and adolescents aged 3 to 18 years with growth failure due to insufficient secretion of endogenous growth hormone (also known as growth hormone deficiency, or GHD). TransCon hGH is a prodrug of somatropin that provides sustained release of unmodified somatropin (hGH) at predictable therapeutic levels in the body.

Key features of the study:

This report provides in-depth analysis of the global somatropin market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global somatropin market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Novo Nordisk A/S, Pfizer, Inc., Eli Lilly and Company, Changchun GeneScience Pharmaceutical Co., Ltd., Sandoz International GmbH, Ipsen Pharma, LG Chem, Merck KGaA, Genentech, Inc., Ferring B.V., AnkeBio Co., Ltd, Reliance Life Sciences, JCR Pharmaceuticals Co., Ltd, Zhongshan Sinobioway Hygene Biomedicine Co., Ltd and USV Private Limited
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global somatropin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global somatropin market

Detailed Segmentation:

Global Somatropin Market, By Dosage Form:
- Powder
- Solvent
Global Somatropin Market, By Application:
- Growth Hormone Deficiency (GHD)
- Turner Syndrome
- Chronic Renal Insufficiency
- Prader Willi Syndrome
- Small for Gestational Age
- SHOX Deficiency
- Others
Global Somatropin Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Somatropin Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Novo Nordisk A/S
- Pfizer, Inc.
- Eli Lilly and Company
- Changchun Gene Science Pharmaceutical Co., Ltd.
- Sandoz International GmbH
- Ipsen Pharma
- LG Chem
- Merck KGaA
- Genentech, Inc.
- Ferring B.V.
- AnkeBio Co., Ltd
- Reliance Life Sciences
- JCR Pharmaceuticals Co., Ltd
- Zhongshan Sinobioway Hygene Biomedicine Co., Ltd
- USV Private Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Dosage Form
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Merger, Acquisition, Collaborations
- Funding and Investment
- Product Approvals/Launches
- Regulatory Guidelines
- Key Developments
- PEST Analysis
- PORTER's Analysis

4. Global Somatropin Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Somatropin Market, By Dosage Form, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Solvent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Global Somatropin Market, By Application, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segments Trends
Growth Hormone Deficiency (GHD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Turner Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Chronic Renal Insufficiency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Prader Willi Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Small for Gestational Age
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
SHOX Deficiency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Somatropin Market, By Distribution Channel, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segments Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Global Somatropin Market, By Region, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Changchun GeneScience Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sandoz International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ipsen Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
LG Chem
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Genentech, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ferring B.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AnkeBio Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Reliance Life Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
JCR Pharmaceuticals Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zhongshan Sinobioway Hygene Biomedicine Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
USV Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

生長激素市場:劑型，各用途，各流通管道，各地區-規模，佔有率，展望，機會分析，2023年～2030年

Somatropin Market, By Dosage Form, By Application, By Distribution Channel, and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)-Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

市場動態

本調查的主要特徵

目錄

第1章調查目的與前提條件

第2章市場概況

第3章市場動態，法規，趨勢分析

第4章全球生長激素市場-COVID-19影響分析

第5章生長激素的全球市場:劑型，2018-2030年

第6章生長激素的全球市場:各用途，2018-2030年

第7章生長激素的全球市場:各流通管道，2018年～2030年

第8章生長激素的全球市場:各地區，2018-2030年

第9章競爭情形

第10章章節

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Somatropin Market- COVID-19 Impact Analysis

5. Global Somatropin Market, By Dosage Form, 2018-2030, (US$ Billion)

6. Global Somatropin Market, By Application, 2018-2030, (US$ Billion)

7. Global Somatropin Market, By Distribution Channel, 2018-2030, (US$ Billion)

8. Global Somatropin Market, By Region, 2018-2030, (US$ Billion)

9. Competitive Landscape

10. Section

生長激素市場:劑型，各用途，各流通管道，各地區-規模，佔有率，展望，機會分析，2023年～2030年

Somatropin Market, By Dosage Form, By Application, By Distribution Channel, and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)-Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

市場動態

本調查的主要特徵

目錄

第1章 調查目的與前提條件

第2章 市場概況

第3章 市場動態，法規，趨勢分析

第4章 全球生長激素市場-COVID-19影響分析

第5章 生長激素的全球市場:劑型，2018-2030年

第6章 生長激素的全球市場:各用途，2018-2030年

第7章 生長激素的全球市場:各流通管道，2018年～2030年

第8章 生長激素的全球市場:各地區，2018-2030年

第9章 競爭情形

第10章 章節

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Somatropin Market- COVID-19 Impact Analysis

5. Global Somatropin Market, By Dosage Form, 2018-2030, (US$ Billion)

6. Global Somatropin Market, By Application, 2018-2030, (US$ Billion)

7. Global Somatropin Market, By Distribution Channel, 2018-2030, (US$ Billion)

8. Global Somatropin Market, By Region, 2018-2030, (US$ Billion)

9. Competitive Landscape

10. Section

第1章調查目的與前提條件

第2章市場概況

第3章市場動態，法規，趨勢分析

第4章全球生長激素市場-COVID-19影響分析

第5章生長激素的全球市場:劑型，2018-2030年

第6章生長激素的全球市場:各用途，2018-2030年

第7章生長激素的全球市場:各流通管道，2018年～2030年

第8章生長激素的全球市場:各地區，2018-2030年

第9章競爭情形

第10章章節